Skip to main content
. 2023 May 13;31(7):1960–1978. doi: 10.1016/j.ymthe.2023.05.007

Figure 3.

Figure 3

Summary of reported mutation rates of rare lung cancers

Mutation rates are presented in descending order. Each column represents a cohort that has received genetic detection and a corresponding reference is provided below each column. Genes with a reported mutation in at least one case are included. Gray checks represent genes that were not detected or not available. Percentages represent the mutation rates. Targets approved by FDA are highlighted in bold and red font.